Results 231 to 240 of about 166,203 (279)

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey

Clinical &Experimental Allergy, EarlyView.
Using data from 17,093 participants in the 2022 Australian National Health Survey, this study is the first to report nationwide prevalence estimates for allergic rhinitis (23.9%), food allergy (7.0%), drug allergy (5.2%), eczema (1.6%) and diagnosed asthma (10.8%) across Australia.
Yichao Wang, Jennifer J. Koplin, Janet M. Davies, Constance H. Katelaris, Debra J. Palmer, Jason A. Trubiano, Joy Lee, Michaela Lucas, Michael O′Sullivan, Sandra Vale, Sheryl van Nunen, Troy Wanandy, Dianne E. Campbell, Kirsten P. Perrett, Rachel L. Peters   +14 more
wiley   +1 more source

Characterization of Prurigo Nodules in Adults With Moderate-To-Severe Atopic Dermatitis in Japan: A 2-Year Observational Study. [PDF]

J Dermatol
Kataoka Y, Etoh T, Saeki H, Katoh N, Teramukai S, Tajima Y, Bosman K, Ardeleanu M, Arima K.   +8 more
europepmc   +1 more source

Dupilumab Is Safe and Efficacious for Treatment of Eosinophilic Esophagitis and Atopic Dermatitis in Pediatric Liver Transplant Recipients: A Case Series. [PDF]

Pediatr Transplant
Yuen C, Wozniak LJ, Cotliar R, Venick RS.   +3 more
europepmc   +1 more source

Revisiting methylprednisolone aceponate: efficacy, safety and current positioning. [PDF]

Drugs Context
Piquero-Casals J, De Lucas R, Mir-Bonafé JF, Rozas-Muñoz E, Lin SC, Brown A, Prudkin L, Foyaca M, Morgado-Carrasco D, Garcia-Patos Briones V.   +9 more
europepmc   +1 more source

Salivary OMICS factors associated with atopic dermatitis in early infancy. [PDF]

Pediatr Allergy Immunol
Alomeir N, Chinchilli E, Terio C, Zhang L, Beck LA, Assery N, Mao X, Wolf JR, Xiao J, Wu T.   +9 more
europepmc   +1 more source

Innate host defense lysozyme may help control <i>Staphylococcus aureus</i> in atopic dermatitis. [PDF]

Microbiol Spectr
Schlievert PM, Kilgore SH, Berdyshev E, Nodzenski M, David G, Yoshida T, Beck LA, Leung DYM.   +7 more
europepmc   +1 more source

Summary of Research: Dupilumab Safety for Treating Infants to Adults with Moderate-to-Severe Atopic Dermatitis. [PDF]

Adv Ther
Langley RG, Gherardi G, Coleman A, Ardeleanu M, Rodríguez-Marco A, Levy S, Bansal A, Chen Z, Rossi AB, Shumel B, Khokhar FA.   +10 more
europepmc   +1 more source

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment

Clinical &Experimental Allergy, Volume 55, Issue 3, Page 260-263, March 2025.
Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, C. F. den Hartog Jager, Marlies de Graaf, Marjolein S. de Bruin‐Weller, Femke van Wijk, Edward F. Knol   +7 more
wiley   +1 more source

Atopic dermatitis [PDF]

Nature Reviews Disease Primers, 2018
Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not completely understood, it appears to result from the complex interplay between defects in skin barrier function, environmental and infectious ...
Kenji Kabashima, Lisa Beck, Thomas Bieber   +2 more
exaly   +10 more sources

Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention [PDF]

Journal of Allergy and Clinical Immunology, 2014
BackgroundAtopic dermatitis (atopic eczema) is a chronic inflammatory skin disease that has reached epidemic proportions in children worldwide and is increasing in prevalence.
Wh McLean, Kim Thomas, Joanne Chalmers   +2 more
exaly   +2 more sources